Cargando…

Secretogranin II influences the assembly and function of MHC class I in melanoma

Melanoma is the deadliest form of skin cancer showing rising incidence over the past years. New insights into the mechanisms of melanoma progression contributed to the development of novel treatment options, such as immunotherapies. However, acquiring resistance to treatment poses a big problem to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steinfass, Tamara, Poelchen, Juliane, Sun, Qian, Mastrogiulio, Giovanni, Novak, Daniel, Vierthaler, Marlene, Pardo, Sandra, Federico, Aniello, Hüser, Laura, Hielscher, Thomas, Carretero, Rafael, Offringa, Rienk, Altevogt, Peter, Umansky, Viktor, Utikal, Jochen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007832/ https://www.ncbi.nlm.nih.gov/pubmed/36906639 http://dx.doi.org/10.1186/s40164-023-00387-1

Ejemplares similares

ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6
por: Vierthaler, Marlene, et al.
Publicado: (2022)

HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma
por: Hüser, Laura, et al.
Publicado: (2020)

T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells
por: Granados, Karol, et al.
Publicado: (2020)

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
por: Federico, Aniello, et al.
Publicado: (2020)

Cellular Reprogramming—A Model for Melanoma Cellular Plasticity
por: Granados, Karol, et al.
Publicado: (2020)

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies
por: Hüser, Laura, et al.
Publicado: (2019)

IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
por: Weber, Rebekka, et al.
Publicado: (2020)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
por: Fleming, Viktor, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
por: Weber, Rebekka, et al.
Publicado: (2018)

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
por: Arkhypov, Ihor, et al.
Publicado: (2022)

Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
por: Arkhypov, Ihor, et al.
Publicado: (2020)

Regulatory Peptides from Chromogranin A and Secretogranin II
por: Helle, Karen B.
Publicado: (2010)

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
por: Umansky, Viktor, et al.
Publicado: (2016)

Loss of tumorigenic potential upon transdifferentiation from keratinocytic into melanocytic lineage
por: Fehrenbach, Sabrina, et al.
Publicado: (2016)

Leukocyte Count Restoration Under Dabrafenib Treatment in a Melanoma Patient With Vemurafenib-Induced Leukopenia: Case Report
por: Orouji, Elias, et al.
Publicado: (2014)

Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?
por: Tolle, Fabrice, et al.
Publicado: (2021)

An antibody against secretogranin I (chromogranin B) is packaged into secretory granules
Publicado: (1989)

Conditional knockout of the secretogranin II gene to reveal biological functions of secretoneurin
por: Leierer, Johannes, et al.
Publicado: (2008)

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
por: Bitsch, Rebekka, et al.
Publicado: (2022)

TRPV1, TRPA1, and TRPM8 are expressed in axon terminals in the cornea: TRPV1 axons contain CGRP and secretogranin II; TRPA1 axons contain secretogranin 3
por: Schecterson, Leslayann C., et al.
Publicado: (2020)

Mysterious inhibitory cell regulator investigated and found likely to be secretogranin II related
por: Hart, John E., et al.
Publicado: (2017)

Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy
por: LeBlanc, Michelle E., et al.
Publicado: (2017)

Epitope mapping of an uncertain endogenous antigen implies secretogranin II peptide splicing
por: Howlett, David R., et al.
Publicado: (2019)

Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches
por: Pievani, Alice, et al.
Publicado: (2021)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

Secretogranin II; a Protein Increased in the Myocardium and Circulation in Heart Failure with Cardioprotective Properties
por: Røsjø, Helge, et al.
Publicado: (2012)

Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy
por: Ji, Liyang, et al.
Publicado: (2023)

New role of ID3 in melanoma adaptive drug-resistance
por: Sachindra,, et al.
Publicado: (2017)

Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
por: Brekk, Oeystein R., et al.
Publicado: (2018)

Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects
por: Sundin, Johanna, et al.
Publicado: (2018)

Machine learning-featured Secretogranin V is a circulating diagnostic biomarker for pancreatic adenocarcinomas associated with adipopenia
por: Jo, Yunju, et al.
Publicado: (2022)

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
por: Lepper, Alisa, et al.
Publicado: (2023)

Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
por: Groth, Christopher, et al.
Publicado: (2021)

Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
por: Bernhardt, Mathias, et al.
Publicado: (2017)

Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364–384))
por: Biswas, Nilima, et al.
Publicado: (2010)

Serum Secretogranin III Concentrations Were Increased in Subjects with Metabolic Syndrome and Independently Associated with Fasting Plasma Glucose Levels
por: Lin, Chun-Chung, et al.
Publicado: (2019)

Proteomic characterization of secretory granules in dopaminergic neurons indicates chromogranin/secretogranin-mediated protein processing impairment in Parkinson’s disease
por: Wen, Gehua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ufleopqsk59v0omnp2n0cm7gge